Hydromorphone Hydrochloride Tablet, Extended Release
Product Images NDC 0574-0293

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0574-0293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0g978rcf3

This is a medication guide for a prescription drug called HYDROmorphone HCI. It is an extended-release tablet for opioid-tolerant patients only, and each tablet contains 12 mg of Hydromorphone Hydrochloride USP. The package contains 100 tablets and a medication guide for patients. Patients should swallow the tablets whole and not break, crush, or chew them. Dosage information is provided in the package insert. The drug should be stored at 20° to 25°C (68° to 77°F), according to USP Controlled Room Temperature guidelines. The manufacturer is Perrigo, located in Minneapolis, MN, as indicated by the label.*

FDA Label Image

1b578rcf3

FDA Label Image

5p178rcf2

This is a drug called HYDROmorphone HCI, which is available in extended-release tablets of 32 mg. It is meant only for patients who have shown tolerance to opioids. Each pack contains 100 such tablets which should not be chewed, crushed, or broken. The medication guide should be provided to each patient with the drug. More information regarding dosing can be obtained from the package insert. It is manufactured by Perrigo. The GTIN and NDC codes are also provided.*

FDA Label Image

6p278rcf3

This is a medication description for a tablet containing 16mg of Hydromorphone Hydrochloride USP for once-daily, extended-release usage. The tablet should not be crushed, chewed or broken while consuming. It is recommended for opioid users and each pack is required to be accompanied by a medication guide. The manufacturer is Perrigo and the tablets should be stored at controlled room temperature. The text also includes product codes and other manufacturing details.*

FDA Label Image

Figure-2.jpg (Figure 2)

This text provides data on the percentage of pain reduction/improvement in patients who were treated with Hydromorphone Hydrochloride Extended-Release Tablets compared to those who were given a placebo after 12 weeks. The exact percentage of improvement or reduction is not given.*

FDA Label Image

Figure One

This appears to be a graph (Figure 1) showing the mean steady-state plasma concentration profile of hydromorphone hydrochloride extended-release tablets (16 mg q24h) and HMIR 4mg geh, based on measurements of plasma hydromorphone (in nanograms per milliliter) over time (in hours).*

FDA Label Image

Chemical-structure (Image 01)

FDA Label Image

Serialization Template 01

This is a template for a product label or packaging that requires the insertion of the specific product's serial number, lot number and expiration date. It could be used for a variety of products such as pharmaceuticals, food items or electronics.*

FDA Label Image

Serialization Template 02

This text provides a template for inserting a product's serial number, lot number, and expiration date for tracking and identification purposes. It does not provide any information about the actual product or its features.*

FDA Label Image

Serialization Template 03

This text provides instructions for inserting a product's serial number, lot number, and expiration date. It could be part of a labeling or tracking system for inventory management.*

FDA Label Image

Serialization Template

This is a document requesting the input of the product's serial number, lot number, and expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.